Format

Send to

Choose Destination
J Hepatol. 2010 Nov 23. [Epub ahead of print]

WITHDRAWN: Low dose ribavirin for treatment of HCV infected thalassemia major patients: New indications for combination therapy.

Author information

1
Baqiyatallah University of Medical Sciences, Baqiyatallah Research Center for Gastroenterology and Liver Disease, Tehran, Iran.

Abstract

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

PMID:
21145858
DOI:
10.1016/j.jhep.2010.10.026

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center